TL;DR: Four options are realistically open to a small cap in 2026. A convertible note is typically the fastest and cheapest, while an equity round brings capital and new decision-makers together. Reg A+ Tier 2 reaches US retail investors, but qualification takes months. A token sale is the strongest choice for a company whose value sits in a network, because it keeps the cap table intact and reaches a global buyer base. It can also run beside a Reg A+ offering rather than replace it.
Raising capital is still one of the most reliable ways for a company to grow, for small caps and large caps alike. The methods are familiar enough. A priced equity round, a convertible note, a bank facility, or a Reg A+ offering when public investors are the target. What many companies still miss is that the shape of the capital market has changed underneath those options. Crypto is no longer a side experiment running parallel to real finance. A token sale now sits on the same menu as the instruments above.
The flows show it. Crypto companies raised $12.86 billion across 271 completed transactions in Q2 2026, according to CryptoRank, with venture capital spreading $4.99 billion of that across 218 rounds. Token sales ran alongside those equity rounds, through ICO, IDO and IEO formats.
Individual token raises are smaller, but they close fast. MMAON raised $800,000 within a two-hour sale window in the 2026 cycle, while Helio is targeting $3 million across private and public phases.
The legal picture moved at the same pace. On January 28, 2026, SEC staff issued a joint statement on tokenized securities. The message was simple. Securities laws apply whether or not a security is tokenized. Manhattan Street Capital reads the practical effect for small caps plainly. Nothing about the Reg A+ route changes, and Tier 2 still caps at $75 million a year.
That combination is what makes a real side-by-side worth running now.
The Four Capital Raise Options
As covered in the previous part, four options are realistically open to a small cap, and each solves a different problem. Knowing what each instrument does, and what it costs in return, will narrow the choice fast.
Token sale
A token sale involves selling digital assets linked to a specific network or product. These digital assets take the form of crypto tokens. Buyers acquire the tokens along with programmed rights, such as utility functions or access to the network. However, buyers typically do not receive equity, board seats, or liquidation preference rights. That makes token sales an option for companies unwilling to give up equity. The structures vary in who distributes the token and who screens the buyers, which is the practical difference between ICO, IDO and IEO formats. That structural choice, and how the token sale itself is designed, decides whether the raise reads as a product launch or an unregistered securities offering.
Equity round
An equity round involves selling shares in the company at an agreed valuation. Investors acquire real ownership along with the rights attached to it, including information rights and protective terms. In most rounds, larger investors also negotiate a board seat. An equity round therefore delivers capital and new decision-makers in one transaction. The valuation must be settled before anything closes, which is what makes this option slower than it looks on paper.
Convertible note
A convertible note is debt issued now that converts into equity at a later priced round. Investors lend money today and receive shares when the next round sets a valuation. In exchange for waiting, they receive a discount, a valuation cap, or both. A convertible note defers the valuation argument rather than resolving it. The note also carries interest and a maturity date, so the obligation remains real until conversion happens.
Reg A+ Tier 2
Regulation A+ Tier 2 allows a company to raise up to $75 million from the public in any twelve-month period, a limit set by the SEC. Both accredited and non-accredited investors can participate, which separates it from a standard private placement. The offering must first be qualified by the SEC through a Form 1-A filing. The company accepts a disclosure obligation that outlives the raise, through annual, semiannual and current reports.
Token Sale vs Equity vs Convertible Notes vs Reg A+: The Side-by-Side
The definitions above explain what each option is. They do not explain how the four behave once placed next to each other. Most founders can describe each instrument in isolation, yet far fewer have seen them measured against the same criteria at the same time.
Six measures decide most capital raise decisions in practice. Dilution, cost, speed, investor base, disclosure load and control. The table below lines up all four options against those six.
Token sale | Equity round | Convertible note | Reg A+ Tier 2 | |
Dilution | No cap table dilution, token supply dilution instead | Immediate and permanent | Deferred, often larger at conversion | Immediate, spread across many holders |
Cost driver | Legal structuring, listing, distribution | Negotiation and diligence | Lowest upfront | Legal, audit, intermediary, marketing |
Time to close | Weeks to months once structure is set | One to six months | Fastest to paper | Months to qualification, then the raise |
Investor base | Global, retail-heavy, product-aligned | Institutional and angel | Existing and insider-led | US retail plus accredited, worldwide |
Disclosure load | Jurisdiction-dependent. No SEC qualification step when the token is not offered as a security to US investors | Private, contractual | Private, contractual | Form 1-A, then 1-K, 1-SA and 1-U filings |
Control impact | Community expectation, no board seat | Board seats and veto rights | Deferred control transfer | Dispersed holders, limited concentration |
Dilution Works Differently in a Token Raise and an Equity Round
Every founder understands equity dilution. Token dilution gets less attention, and it is the reason the word non-dilutive causes so much trouble.
In a priced round, each share issued reduces the founders' percentage permanently. The arithmetic is visible on the cap table and settled at signing. Nobody misreads it.
A token sale leaves that cap table untouched, which is the honest part of the pitch. The accurate framing is that capital can be raised without giving up equity, not that nothing gets diluted. Every token released against a fixed supply reduces the share held by earlier buyers.
The difference that matters is where the pressure lands. Equity dilution is absorbed once by a small group of sophisticated holders. Token dilution is absorbed continuously by a public market that prices the unlock schedule in real time.
A convertible note sits in between. It postpones dilution and usually deepens it, because the discount or cap converts at terms agreed before the company had leverage.
Cost and Speed: Which Capital Raise Closes Fastest and Costs Least
On cost and speed alone, a convertible note wins. The documents are standard, no valuation needs to be agreed, and no regulator reviews the raise before the money arrives. Most close within 1 to 2 weeks of signature.
Reg A+ is the slowest. SEC staff research on the first years of Reg A+ found a median of 78 days from the first public filing to qualification, as reported by Crowdfund Insider. The same research reported median legal costs of about $40,000 to $50,000 and median audit costs of about $15,000. Those are lookback figures, so current offerings may differ. Preparation and the audit happen before those 78 days begin, adding 2 to 3 months to the total calendar.
A token sale can avoid the qualification step. That holds when the token is structured as a non-security and US investors are excluded. The timeline then compresses against Reg A+. The cost shifts instead to jurisdiction selection, legal opinions, token design, listing and custody.
Structuring and legal opinions. 4 to 8 weeks.
Listing and distribution. 2 to 4 weeks.
Utility token legal structuring. $15,000 to $30,000 depending on jurisdiction and whether the issuer is US-based or offshore.
Governance and asset-backed tokens. Higher costs due to additional regulatory review.
Token sales run materially cheaper on the legal side than Reg A+'s median $40,000 to $50,000 when the token function is clear from the start.
Speed is a weak reason to choose any of them. The stronger question is what the capital is for, and that is where the four options separate.
The cost nobody budgets for is filling the raise
Permission to sell is not the same as money in the bank. Reg A+ allows public marketing, so the offering only works with steady advertising and investor relations spent behind it.
Token sales have the same problem in a different form. Community building, market making and token sale marketing before the pre-sale typically run for months before launch. Teams that only spend on marketing in launch week usually raise less than planned.
Compliance Load of Each Capital Raise in 2026
A token sale carries the most variable compliance load of the four options. Equity rounds and convertible notes follow known private placement rules. Reg A+ follows a published SEC process. A token sale has no single path, so the obligations depend on choices the team makes during structuring.
Those choices became easier to judge in 2026. On January 28, SEC staff issued a joint statement on tokenized securities, written by three divisions. It defined how tokenized securities are classified. The staff emphasized that securities laws apply whether or not a security is tokenized. Neither the format of issuance nor the method of recording holders changes which rules apply.
For a small cap, that settles one question permanently. Putting an instrument on a blockchain does not move it outside the securities rules. What matters is what the instrument does, not what format it is issued in.
The statement also separated issuer-sponsored tokenized securities from third-party sponsored ones, as explained by Manhattan Street Capital. A company issuing its own tokenized security follows the issuer-sponsored path. The third-party synthetic model carries different risks. A token structured as a security-based swap cannot be sold to ordinary investors unless it is registered and traded on a national securities exchange.
Four decisions set the compliance load of a token sale, and all four are made before any token is sold:
The jurisdiction the issuing entity sits in, and the rules that apply there
What the token actually does, since function decides how it is classified
Who is allowed to buy, including whether US investors can participate
How the sale is promoted, because marketing claims create most of the avoidable risk
The fourth point is the one teams underestimate. Marketing is where the exposure accumulates, which is why a token sale marketing compliance checklist belongs in the structuring phase and not after the copy goes live.
By comparison, the other three options are predictable. Equity rounds and convertible notes rely on private placement exemptions and contractual disclosure. Reg A+ carries the heaviest load of the four, but also the clearest, through Form 1-A and continuing reports after qualification.
Is a Token Sale Better Than a Convertible Note?
For a company building a network, yes. A convertible note funds a company and delays the valuation question. A token sale funds the network itself and brings in the people who will use it. For a company whose value sits in users rather than in a balance sheet, that difference decides the outcome.
Helio Corporation, a TokenMinds client, is a working example. The aerospace company entered Web3 to fund a space-based solar power network, and chose a token sale over an equity route. The reasoning followed the network logic above. The cap table stayed intact, and the buyer base could be global rather than institutional. Helio is targeting $3 million through a private sale and an IDO, structured to prove the model before moving to larger exchanges.
Where a Token Sale Wins
Five conditions decide whether a token sale is the stronger choice:
The token has a real job. Networks with active usage, products with an access layer, and ecosystems with real throughput give buyers a reason to hold the token rather than resell it. A governance token that holders vote with on protocol changes, or an access token that unlocks API usage or network features, creates that reason. A token that exists only to represent a claim on future revenue does not.
The buyer base is global. Buyers do not need a US broker relationship to participate, so a token sale reaches people that a private round never touches, though US investors are often excluded to keep the structure clean.
Control stays intact. No board seat is created, and no liquidation preference sits above the founders.
Pricing is settled once. A note only postpones the valuation argument, and that argument returns at the next round with worse terms.
The buyers are users. A note brings in lenders waiting for conversion, while a token sale brings in people with a reason to help the network grow.
Where a Token Sale Loses
Two conditions work against it:
The token has no function. A token that exists only to raise money is still a security, but with extra steps and a public price chart attached to it.
The price moves every day. The market judges the team's execution in public long before the roadmap is delivered. That pressure is real, though it is the same pressure any listed company accepts in exchange for public capital.
A Token Sale Can Sit Alongside Reg A+, Not Replace It
Most companies treat this as a choice between one option and another. In practice, the two can run at the same time.
A Reg A+ offering raises equity capital from US retail investors. A token sale funds a network and distributes it among users. Different buyers, different instruments, different jobs. A company that needs both can run both.
Tokenizing a Reg A+ offering does not change the exemption
The rules stay the same whether the securities are issued in normal book-entry form or in tokenized form, according to Manhattan Street Capital. The company still needs SEC qualification, still files an offering circular, and still follows the same investor rules.
What changes is the recordkeeping. The company must explain which blockchain it uses, how transfers work, and what happens if the system fails.
Matching the Capital Raise to the Company
Fit comes down to three inputs. What the capital buys, where the buyers are, and whether a token has a function.
Situation | Best fit |
Bridge to a priced round, insiders available | Convertible note |
Institutional capital, clear valuation, operating business | Equity round |
US retail demand, brand with a customer base, $10M and up | Reg A+ Tier 2 |
Network or product with real usage and a functional token | Token sale |
US retail reach plus a network to fund | Reg A+ and a token sale together |
Most small caps that consider a token sale actually need a comparison of the options first. Specialist capital raising services exist for exactly that sequencing problem.
Five Checks Before Committing to a Capital Raise
Each check narrows the list. Run them in order and the right option usually becomes obvious.
Check what the capital is for.
Funding a company points to a note or an equity round. Funding and distributing a network points to a token sale.Check the timeline.
A note closes in one to two weeks. A token sale takes weeks to months of structuring. Reg A+ runs months, with a median of 78 days for qualification alone.Check where the buyers are.
US retail investors point to Reg A+. A global buyer base without broker relationships points to a token sale.Check the regulation that applies.
Private placements follow known exemptions. Reg A+ follows a published SEC process. A token sale depends on jurisdiction, token function and who is allowed to buy.Check the budget on both sides.
Legal and audit costs have a ceiling. Reaching buyers does not, and Reg A+ and token sales both need months of spend before the money arrives.
Common Mistakes Founders Make With Each Instrument
Convertible notes turn on the cap, and that is where founders get caught. If the next round prices above the cap, the note converts at the cap instead of the round price, so early investors take a larger share than the headline terms suggested. The company then either accepts that outcome or reopens the terms with an investor who has no reason to agree.
Equity rounds are slower than founders expect because valuation negotiation takes longer than the legal paperwork. The diligence phase, not the signature, is where most rounds stall. Founders who budget for 90 days often need 120 or more.
Reg A+ offerings fail to raise their target because founders underestimate the cost of reaching retail investors. Permission to market is not the same as a customer acquisition channel.
Token sales fail when founders design the token first and ask what it does second. The function has to be settled before the supply schedule, the sale mechanics or the marketing copy exist, because every one of those depends on it. Teams that reverse the order usually end up rebuilding the token after the structuring work is already paid for.
Get a Token Fundraising Fit Assessment With TokenMinds
A token sale is the strongest option for a company whose value sits in a network rather than a balance sheet. It reaches a global buyer base, keeps the cap table intact, and brings in people who have a reason to use what the company builds. The difficulty is that the result depends almost entirely on how the sale is structured before it opens.
TokenMinds has run token sales end to end since 2016, and works on token sale strategy, tokenomics, and go-to-market for companies that are not crypto-native. The work covers token design and supply schedules built to survive post-launch scrutiny, sale mechanics and pricing, jurisdiction and legal structuring with partner counsel, investor acquisition, and exchange or listing execution. Its token fundraising fit assessment reviews the raise goal, stage, cap table and investor geography in one pass, so the team leaves with a token sale structure that fits, the claims that will not survive diligence, and a clear answer on whether the sale should run on its own or beside a Reg A+.
Book a token fundraising fit assessment with TokenMinds.
Frequently Asked Questions
Is a token sale better than a convertible note for a small-cap company?
For a company building a network, yes. A token sale funds the network itself, reaches a global buyer base, and creates no board seat or liquidation preference. A convertible note is the better choice only when the company needs a fast bridge and has no token with a real function.
Token sale vs Reg A+: which is cheaper and faster for raising capital?
A token sale is faster when the token is structured as a non-security and US investors are excluded, because there is no SEC qualification step. Reg A+ takes a median of 78 days from public filing to qualification, plus preparation, audit and ongoing reporting. A token sale still carries real cost in structuring, listing and distribution, so the saving is in time more than in money.
How does dilution compare between a token raise and an equity round?
An equity round reduces ownership permanently and visibly on the cap table. A token raise leaves the cap table untouched and dilutes token holders instead, as supply unlocks. Founders keep their company, and the dilution moves to a different asset priced by a public market.
